NCT00165555View on ClinicalTrials.gov

Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

April 30, 2002

Study Completion Date

November 30, 2009

Conditions
Pleural MesotheliomaMalignant Pleural Mesothelioma
Interventions
DRUG

Cisplatin

Given as a heated one-hour lavage to the hemithorax after surgery.

DRUG

Sodium Thiosulfate

Given intravenously over 6 hours after the cisplatin lavage.

Trial Locations (2)

02115

Brigham and Women's Hospital, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00165555 - Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma | Biotech Hunter | Biotech Hunter